Update on Recent Developments in Small Molecular HIV-1 RNase H Inhibitors (2013-2016): Opportunities and Challenges

Author(s): Xueshun Wang , Ping Gao , Luis Menendez-Arias , Xinyong Liu* , Peng Zhan* .

Journal Name: Current Medicinal Chemistry

Volume 25 , Issue 14 , 2018

  Journal Home
Translate in Chinese


Combinations of antiretroviral drugs are successfully used to treat HIV-infected patients. However, drug resistance is a major problem that makes discovery of new antiretroviral drugs an ongoing priority. The ribonuclease H (RNase H) activity of the HIV-1 reverse transcriptase catalyzes the selective hydrolysis of the RNA strand of RNA:DNA heteroduplex replication intermediates, and represents an attractive unexploited target for drug development. This review reports on recent progress in the characterization of HIV-1 RNase H inhibitors from 2013 to 2016, describing their chemical structures, structureactivity relationship and binding modes. Focus is given to emerging medicinal chemistry principles and insights into the discovery and development of RNase H inhibitors.

Keywords: AIDS, HIV-1, RNase H inhibitors, dual inhibitors, drug design, SAR, antiviral, metalloenzyme.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [1682 - 1702]
Pages: 21
DOI: 10.2174/0929867324666170113110839
Price: $58

Article Metrics

PDF: 38